Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal–hippocampal connectome across stages of Alzheimer's disease
- 29 March 2023
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 531 (18) , 2080-2108
Abstract
Neurofibrillary tangles (NFTs) contain abnormally phosphorylated tau proteins, which spread within components of the medial temporal lobe (MTL) memory circuit in Alzheimer's disease (AD). Here, we used quantitative immunohistochemistry to determine the density of posttranslational oligomeric (TOC1 and TNT1), phosphorylated (AT8), and late truncated (TauC3) tau epitopes within the MTL subfields including entorhinal cortex (EC) layer II, subiculum, Cornu Ammonis (CA) subfields, and dentate gyrus (DG) in subjects who died with a clinical diagnosis of no cognitive impairment (NCI), mild cognitive impairment (MCI), and AD. We also examined whether alterations of the nuclear alternative splicing protein, SRSF2, are associated with tau pathology. Although a significant increase in TOC1, TNT1, and AT8 neuron density occurred in the EC in MCI and AD, subicular, DG granule cell, and CA1 and CA3 densities were only significantly higher in AD. TauC3 counts were not different between connectome regions and clinical groups. SRSF2 intensity in AT8‐positive cells decreased significantly in all regions independent of the clinical groups examined. CA1 and subicular AT8, TauC3, and oligomeric densities correlated across clinical groups. EC AT8 counts correlated with CA subfields and subicular and DG values across clinical groups. Oligomeric and AT8 CA1, EC, and subicular density correlated with Braak stage. Decreased nuclear SRSF2 in the presence of cytoplasmic phosphorylated tau suggests a dual‐hit process in NFT formation within the entorhinal hippocampal connectome during the onset of AD. Although oligomeric and phosphorylated tau follow a stereotypical pattern, clinical disease stage determined density of tau deposition and not anatomic location within the entorhinal–hippocampal connectome.Keywords
Funding Information
- BrightFocus Foundation (CA2018010)
- National Institutes of Health (P01AG014449, P30AG028383, R01AG043375, R01AG061566)
This publication has 93 references indexed in Scilit:
- Trans-splicing correction of tau isoform imbalance in a mouse model of tau mis-splicingHuman Molecular Genetics, 2013
- Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transportNeurobiology of Aging, 2012
- Propagation of Tau Pathology in a Model of Early Alzheimer's DiseaseNeuron, 2012
- Progression of Tau Pathology in Cholinergic Basal Forebrain Neurons in Mild Cognitive Impairment and Alzheimer's DiseaseThe American Journal of Pathology, 2011
- Heat Shock Protein 70 Prevents both Tau Aggregation and the Inhibitory Effects of Preexisting Tau Aggregates on Fast Axonal TransportBiochemistry, 2011
- Pathogenic protein seeding in alzheimer disease and other neurodegenerative disordersAnnals of Neurology, 2011
- Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer DiseaseJournal of Biological Chemistry, 2011
- Splicing factor SC35 promotes tau expression through stabilization of its mRNAFEBS Letters, 2011
- A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoformsMolecular Psychiatry, 2007
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991